Doctor of Philosophy

South Africa is short of academic statisticians: why and what can be done

Retrieved on: 
Wednesday, April 10, 2024

463 exabytes of data will be created each day globally – that’s the equivalent of 212,765,957 DVDs per day.

Key Points: 
  • 463 exabytes of data will be created each day globally – that’s the equivalent of 212,765,957 DVDs per day.
  • We are a group of academic statisticians from South African universities who have compiled a discussion paper to address these issues.
  • We have identified the factors contributing to the capacity crisis in academic statistics, including a lack of collaboration between academics in different academic statistical fields.
  • We’ve also proposed a way to improve both the quality and quantity of, primarily, doctoral candidates in the various statistical fields.

What’s in a name?

  • Over the years, a divide has emerged between those who research and lecture in applied statistics and their counterparts in mathematical or theoretical statistics.
  • Statistics departments are positioned within different faculties across various
    South African universities, for example within commerce, natural science, or engineering.
  • A doctoral candidate focused on econometrics may not realise that a biostatistician is well equipped to support and mentor them.

Assessment

  • There may be concerns that standardising assessment for what is essentially creative output (novel, innovative ideas) may be too prescriptive.
  • However, we believe that a semi-flexible assessment rubric is vital.
  • An assessment rubric is an important tool for formative assessment.

Supervisor-student relationship

  • The relationship a PhD candidate has with their supervisor is enormously important, as research from across disciplines has shown.
  • Without sufficient mentoring, early-career supervisors may not know how to nurture a healthy supervisor-student relationship.
  • They may not be aware of all of the intricacies inherent in this relationship, let alone the skills that they should be imparting to their students.

Next steps

  • To our knowledge, it is the first of its kind in the field of academic statistics.
  • Some new supervisors may use the entire guiding rubric to assist in each important area.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Roads of destruction: we found vast numbers of illegal ‘ghost roads’ used to crack open pristine rainforest

Retrieved on: 
Wednesday, April 10, 2024

In an article published today in Nature, my colleagues and I show that illicit, often out-of-control road building is imperilling forests in Indonesia, Malaysia and Papua New Guinea.

Key Points: 
  • In an article published today in Nature, my colleagues and I show that illicit, often out-of-control road building is imperilling forests in Indonesia, Malaysia and Papua New Guinea.
  • Once roads are bulldozed into rainforests, illegal loggers, miners, poachers and landgrabbers arrive.
  • Once they get access, they can destroy forests, harm native ecosystems and even drive out or kill indigenous peoples.
  • All nations have some unmapped or unofficial roads, but the situation is especially bad in biodiversity-rich developing nations, where roads are proliferating at the fastest pace in human history.

Mapping ghost roads

  • This workforce then spent some 7,000 hours hand-mapping roads, using fine-scale satellite images from Google Earth.
  • For starters, unmapped ghost roads seemed to be nearly everywhere.
  • In fact, when comparing our findings to two leading road databases, OpenStreetMap and the Global Roads Inventory Project, we found ghost roads in these regions to be 3 to 6.6 times longer than all mapped roads put together.
  • When ghost roads appear, local deforestation soars – usually immediately after the roads are built.
  • We found the density of roads was by far the most important predictor of forest loss, outstripping 38 other variables.

Roads and protected areas

  • In protected areas, we found only one-third as many roads compared with nearby unprotected lands.
  • The bad news is that when people do build roads inside protected areas, it leads to about the same level of forest destruction compared to roads outside them.
  • Keeping existing protected areas intact is especially urgent, given more than 3,000 protected areas have already been downsized or degraded globally for new roads, mines and local land-use pressures.

Hidden roads and the human footprint

  • To gauge how much impact we’re having, researchers use the human footprint index, which brings together data on human activities such as roads and other infrastructure, land-uses, illumination at night from electrified settlements and so on.
  • When ghost roads are included in mapping the human impact on eastern Borneo, areas with “very high” human disturbance double in size, while the areas of “low” disturbance are halved.

Artificial intelligence

  • Worse, these roads can be actively encouraged by aggressive infrastructure-expansion schemes — most notably China’s Belt and Road Initiative, now active in more than 150 nations.
  • You might think AI could do this better, but that’s not yet true – human eyes can still outperform image-recognition AI software for mapping roads.
  • Once we have this information, we can make it public that so authorities, NGOs and researchers involved in forest protection can see what’s happening.


Distinguished Professor Bill Laurance receives funding from the Australian Research Council and other scientific and philanthropic bodies. He is a former Australian Laureate and director of the Centre for Tropical Environmental and Sustainability Science at James Cook University.

EQS-News: Heidelberg Pharma to host R&D Webinar following novel data presented at AACR

Retrieved on: 
Wednesday, April 10, 2024

Ladenburg, Germany, 5 April 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that it will be hosting an R&D Webinar on 23 April 2024 at 16.00 CEST/15.00 BST, for investors, analysts and media.

Key Points: 
  • Ladenburg, Germany, 5 April 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that it will be hosting an R&D Webinar on 23 April 2024 at 16.00 CEST/15.00 BST, for investors, analysts and media.
  • The event will provide information on Heidelberg Pharma’s lead clinical ATAC product candidate HDP-101 targeting relapsed and refractory multiple myeloma as well as its proprietary ADC toolbox and therapeutic product pipeline.
  • Attendees will have the opportunity to participate in a live Q&A session at the end of the presentation or submit questions in advance of the event.
  • For further information on the R&D webinar, or to register your interest, please contact Optimum Strategic Communications at [email protected] or register using the link below:

EQS-News: Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline

Retrieved on: 
Wednesday, April 10, 2024

Tubulis is developing a pipeline of uniquely matched antibody drug conjugates (ADCs) with an indication-tailored targeting molecule and payload combination to develop novel ADCs with superior properties.

Key Points: 
  • Tubulis is developing a pipeline of uniquely matched antibody drug conjugates (ADCs) with an indication-tailored targeting molecule and payload combination to develop novel ADCs with superior properties.
  • The proceeds of the Series B2 will primarily support progress in Tubulis’ pipeline of next-generation ADCs toward clinical evaluation and help achieve clinical proof-of-concept for lead candidates, TUB-040 and TUB-030.
  • The company expects to start its first Phase 1/2a clinical trial, including dose escalation and dose optimization cohorts in 2024.
  • “This substantial financing from a syndicate of global specialist biotech investors recognizes Tubulis’ unique position in the ADC space.

EQS-News: CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer

Retrieved on: 
Wednesday, April 10, 2024

Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.

Key Points: 
  • Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.
  • Dr. Elisabeth Lackner, CEO of CRS, commented: “I am honoured to join this great management team and to guide the organization into its next chapter of strategic growth and innovation.
  • “Together, we aim to propel CRS to new heights, centred on internationalization, strategic expansion, and a relentless pursuit of excellence."
  • Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.

First Phosphate Reports Published Research Studies for its Lac à l'Orignal, Mirepoix and Bégin-Lamarche Properties in the Saguenay-Lac-St-Jean region of Quebec, Canada

Retrieved on: 
Tuesday, March 26, 2024

Saguenay, Quebec--(Newsfile Corp. - March 26, 2024) - First Phosphate Corp. (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) ("First Phosphate" or the "Company"), is pleased to announce that two peer-reviewed publications in scientific journals and one research report have been published on its phosphate properties at Lac à l'Orignal, Mirepoix and Bégin-Lamarche in the Saguenay-Lac-St-Jean region of Quebec.

Key Points: 
  • Saguenay, Quebec--(Newsfile Corp. - March 26, 2024) - First Phosphate Corp. (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) ("First Phosphate" or the "Company"), is pleased to announce that two peer-reviewed publications in scientific journals and one research report have been published on its phosphate properties at Lac à l'Orignal, Mirepoix and Bégin-Lamarche in the Saguenay-Lac-St-Jean region of Quebec.
  • "High purity Quebec igneous phosphate rock as is found in the Company's properties is believed to be able produce a large quantity of purified phosphoric acid ("PPA") to serve North America's electrification requirements."
  • The three published studies can be found at:
    Petrogenesis of oxide-apatite mineralization associated with Proterozoic anorthosite massifs at Lac Mirepoix, Quebec, Canada: A multi-injection model for Fe-Ti-P mineralization in the Central Grenville Province
    1Pedro Miloski, 1Sarah Dare, 2Caroline-Emmanuelle Morisset, 3Morgann G. Perrot, 3Joshua H.F.L.
  • 1Département des Sciences Appliquées, Université du Québec à Chicoutimi (UQAC); 2Agence Spatiale Canadienne; 3Département des Sciences de la Terre et de l'Atmosphère/GEOTOP, Université du Québec à Montréal (UQAM) Published in Ore Geology Reviews as part of a PhD thesis.

Inc.’s 2024 Female Founders list highlights why female founders are always a good bet

Retrieved on: 
Tuesday, April 9, 2024

Elizabeth Ruzzo, CEO and founder of adyn, was recognized by Inc. in this year’s Female Founders list.

Key Points: 
  • Elizabeth Ruzzo, CEO and founder of adyn, was recognized by Inc. in this year’s Female Founders list.
  • The female founders on this year’s list are a testament to what triumph over adversity looks like.
  • “One thing I bet all founders on this list share is an abundance of grit and determination.
  • Despite years of evidence demonstrating that female founders are a good bet, the fundraising environment remains bleak.

Auron Unveils Preclinical Data Supporting its Lead Program and Ability of its AURIGIN™ Platform to Generate Targeted Cancer Therapies at AACR Annual Meeting

Retrieved on: 
Tuesday, April 9, 2024

NEWTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, today announced two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting. The Company highlighted the distinct ability of its AURIGIN™ platform to identify both cell state plasticity, the proliferative state in which cancer cells grow, and the causative gene targets. In a second poster, Auron shared preclinical data from its program targeting KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung cancer (SCLC), neuroendocrine prostate cancer (NEPC), and acute myeloid leukemia (AML). These data led to the nomination of AUTX-703, an orally available and selective KAT2A/B degrader development candidate, for which Auron expects to file an IND in 2024.

Key Points: 
  • The Company highlighted the distinct ability of its AURIGIN™ platform to identify both cell state plasticity, the proliferative state in which cancer cells grow, and the causative gene targets.
  • In a second poster, Auron shared preclinical data from its program targeting KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung cancer (SCLC), neuroendocrine prostate cancer (NEPC), and acute myeloid leukemia (AML).
  • These data led to the nomination of AUTX-703, an orally available and selective KAT2A/B degrader development candidate, for which Auron expects to file an IND in 2024.
  • “The understanding that cellular plasticity contributes to aggressive and treatment-resistant tumor growth underscores the need for innovative, targeted approaches.

Food & Society at the Aspen Institute Releases the 2024 Food is Medicine Research Action Plan

Retrieved on: 
Tuesday, April 9, 2024

Washington, DC, April 09, 2024 (GLOBE NEWSWIRE) -- Food & Society at the Aspen Institute has released its 2024 Food is Medicine Research Action Plan.

Key Points: 
  • Washington, DC, April 09, 2024 (GLOBE NEWSWIRE) -- Food & Society at the Aspen Institute has released its 2024 Food is Medicine Research Action Plan.
  • It is the first report to pull together the latest peer-reviewed Food is Medicine research in a digestible, comprehensible, and action-oriented format.
  • Associated health outcomes like diabetes and heart disease remain far greater among Black and Latinx individuals and households.
  • Like the original, the revised version of the Research Action Plan has been made possible thanks to the continuing support of the Walmart Foundation.

Study: These Metropolitan Areas are Most at Risk for Pricing Corrections

Retrieved on: 
Tuesday, April 9, 2024

Twelve of the 15 most overpriced housing markets are in Sun Belt states, February data from the Top 100 U.S. Housing Markets shows.

Key Points: 
  • Twelve of the 15 most overpriced housing markets are in Sun Belt states, February data from the Top 100 U.S. Housing Markets shows.
  • Atlanta leads the nation for overpriced cities, with homes 41.72 percent overpriced compared to the long-term pricing trends.
  • Some of the metropolitan areas with the largest housing premiums are more at risk of a correction than they were leading up to the housing crash of 2007.
  • However, renting and not reinvesting is wealth destroying and should never be considered as an option.”
    To compare housing premiums in any metropolitan area, click here .